Literature DB >> 20298260

Direct reprogramming 101.

Kazutoshi Takahashi1.   

Abstract

Direct reprogramming of somatic cells into a pluripotent state has been achieved with a set of just four transcription factors. Many scientists and medical doctors are trying to elucidate the causes of intractable diseases and discover new drugs using the newest types of technology. Various methods have been developed to produce clinical-grade fully reprogrammed cells for cell transplantation therapy. Augmenting agents, such as small-molecules, have been extensively screened to improve the reprogramming efficiency. The molecular mechanisms of reprogramming have been revealed by embryonic stem cell research. The accumulation of knowledge by the pioneers has driven the reprogramming field. In the present article, the contents of gift boxes from the studies of pluripotency to the nuclear reprogramming field are introduced.

Mesh:

Substances:

Year:  2010        PMID: 20298260     DOI: 10.1111/j.1440-169X.2010.01169.x

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  8 in total

Review 1.  Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics.

Authors:  Issei S Shimada; Jeffrey L Spees
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

2.  Examination of DNA methyltransferase expression in cloned embryos reveals an essential role for Dnmt1 in bovine development.

Authors:  Michael C Golding; Gayle L Williamson; Todd K Stroud; Mark E Westhusin; Charles R Long
Journal:  Mol Reprod Dev       Date:  2011-04-08       Impact factor: 2.609

Review 3.  Cell-intrinsic reprogramming capability: gain or loss of pluripotency in germ cells.

Authors:  Masanori Imamura; Zachary Yu-Ching Lin; Hideyuki Okano
Journal:  Reprod Med Biol       Date:  2012-06-19

Review 4.  Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects.

Authors:  Kristina Hug; Göran Hermerén
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

5.  Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.

Authors:  Jianchang Yang; Jerell R Aguila; Zaida Alipio; Raymond Lai; Louis M Fink; Yupo Ma
Journal:  J Hematol Oncol       Date:  2011-09-23       Impact factor: 17.388

Review 6.  MicroRNAs and induced pluripotent stem cells for human disease mouse modeling.

Authors:  Chingiz Underbayev; Siddha Kasar; Yao Yuan; Elizabeth Raveche
Journal:  J Biomed Biotechnol       Date:  2012-04-30

7.  Introduction of Exogenous HSV-TK Suicide Gene Increases Safety of Keratinocyte-Derived Induced Pluripotent Stem Cells by Providing Genetic "Emergency Exit" Switch.

Authors:  Maciej Sułkowski; Paweł Konieczny; Paula Chlebanowska; Marcin Majka
Journal:  Int J Mol Sci       Date:  2018-01-09       Impact factor: 5.923

8.  V-myc immortalizes human neural stem cells in the absence of pluripotency-associated traits.

Authors:  María José Pino-Barrio; Elisa García-García; Pablo Menéndez; Alberto Martínez-Serrano
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.